Harmony Biosciences (HRMY) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free HRMY Stock Alerts $33.58 +0.06 (+0.18%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Harmony Biosciences Short Interest DataCurrent Short Volume6,090,000 sharesPrevious Short Volume6,290,000 sharesChange Vs. Previous Month-3.18%Dollar Volume Sold Short$194.76 millionShort Interest Ratio / Days to Cover16.9Last Record DateMarch 15, 2024Outstanding Shares56,770,000 sharesFloat Size30,740,000 sharesShort Percent of Float19.81%Today's Trading Volume303,545 sharesAverage Trading Volume368,634 sharesToday's Volume Vs. Average82% Short Selling Harmony Biosciences ? Sign up to receive the latest short interest report for Harmony Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHRMY Short Interest Over TimeHRMY Days to Cover Over TimeHRMY Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Harmony Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20246,090,000 shares $194.76 million -3.2%19.8%16.9 $31.98 2/29/20246,290,000 shares $201.91 million -1.9%19.9%15.4 $32.10 2/15/20246,410,000 shares $224.73 million +0.9%20.3%15.1 $35.06 1/31/20246,350,000 shares $200.28 million +1.6%19.5%13.8 $31.54 1/15/20246,250,000 shares $195.75 million +3.5%19.2%10.7 $31.32 12/31/20236,040,000 shares $195.09 million +2.4%18.6%8 $32.30 Get the Latest News and Ratings for HRMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harmony Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/20235,900,000 shares $198.65 million -0.8%18.1%7.8 $33.67 11/30/20235,950,000 shares $172.91 million +0.3%17.9%7.6 $29.06 11/15/20235,930,000 shares $149.44 million +11.1%17.9%7.4 $25.20 10/31/20235,340,000 shares $125.70 million -22.6%16.1%6.8 $23.54 10/15/20236,900,000 shares $145.66 million -1.6%20.3%9.4 $21.11 9/30/20237,010,000 shares $229.72 million -4.6%20.6%12.4 $32.77 9/15/20237,350,000 shares $275.77 million -5.0%21.6%13.8 $37.52 8/31/20237,740,000 shares $280.58 million +3.8%22.8%15.7 $36.25 8/15/20237,460,000 shares $245.36 million -2.1%22.0%16.6 $32.89 7/31/20237,620,000 shares $269.52 million -8.5%22.6%16.7 $35.37 7/15/20238,330,000 shares $294.47 million -1.2%24.7%16.7 $35.35 6/30/20238,430,000 shares $296.65 million +2.9%25.0%15.7 $35.19 6/15/20238,190,000 shares $297.05 million +2.1%24.3%9.6 $36.27 5/31/20238,020,000 shares $277.33 million +0.6%23.9%9.2 $34.58 5/15/20237,970,000 shares $291.22 million -2.3%23.8%8.5 $36.54 4/30/20238,160,000 shares $263.08 million +2.1%24.4%8.6 $32.24 4/15/20237,990,000 shares $251.76 million +7.0%24.1%8.9 $31.51 3/31/20237,470,000 shares $243.90 million +19.0%22.6%8 $32.65 3/15/20236,280,000 shares $255.22 million +8.3%19.0%10.6 $40.64 2/28/20235,800,000 shares $255.37 million +8.0%17.5%10.5 $44.03 2/15/20235,370,000 shares $262.16 million +5.5%16.3%10.2 $48.82 1/31/20235,090,000 shares $245.19 million -3.8%15.5%10.7 $48.17 1/15/20235,290,000 shares $250.85 million +21.1%16.2%10.5 $47.42 12/30/20224,370,000 shares $240.79 million +9.3%13.3%8.9 $55.10 12/15/20224,000,000 shares $224.52 million -26.1%12.5%8.8 $56.13 11/30/20225,410,000 shares $323.36 million -4.6%17.0%10.9 $59.77 11/15/20225,670,000 shares $318.09 million -1.7%17.8%11.5 $56.10 10/31/20225,770,000 shares $300.04 million +0.2%18.5%11.3 $52.00 10/15/20225,760,000 shares $294.16 million -5.0%18.5%10.8 $51.07 9/30/20226,060,000 shares $268.40 million +5.6%19.5%11.2 $44.29 9/15/20225,740,000 shares $257.96 million +9.5%18.5%10.1 $44.94 8/31/20225,240,000 shares $230.09 million +2.8%16.9%9.6 $43.91 8/15/20225,100,000 shares $259.59 million +3.0%16.4%9.4 $50.90 7/31/20224,950,000 shares $251.11 million +5.8%16.6%9.2 $50.73$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. HRMY Short Interest - Frequently Asked Questions What is Harmony Biosciences' current short interest? Short interest is the volume of Harmony Biosciences shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 6,090,000 shares of HRMY short. 19.81% of Harmony Biosciences' shares are currently sold short. Learn More on Harmony Biosciences' current short interest. What is a good short interest ratio for Harmony Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HRMY shares currently have a short interest ratio of 17.0. Learn More on Harmony Biosciences's short interest ratio. Which institutional investors are shorting Harmony Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Harmony Biosciences: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Harmony Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.81% of Harmony Biosciences' floating shares are currently sold short. Is Harmony Biosciences' short interest increasing or decreasing? Harmony Biosciences saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 6,090,000 shares, a drop of 3.2% from the previous total of 6,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Harmony Biosciences' float size? Harmony Biosciences currently has issued a total of 56,770,000 shares. Some of Harmony Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harmony Biosciences currently has a public float of 30,740,000 shares. How does Harmony Biosciences' short interest compare to its competitors? 19.81% of Harmony Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Harmony Biosciences: Syndax Pharmaceuticals, Inc. (9.80%), Geron Co. (9.33%), Amneal Pharmaceuticals, Inc. (1.87%), Schrödinger, Inc. (8.19%), Catalyst Pharmaceuticals, Inc. (5.84%), Supernus Pharmaceuticals, Inc. (9.39%), Ardelyx, Inc. (15.60%), Avidity Biosciences, Inc. (10.81%), Structure Therapeutics Inc. (8.18%), Morphic Holding, Inc. (12.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Harmony Biosciences stock? Short selling HRMY is an investing strategy that aims to generate trading profit from Harmony Biosciences as its price is falling. HRMY shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harmony Biosciences? A short squeeze for Harmony Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HRMY, which in turn drives the price of the stock up even further. How often is Harmony Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRMY, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Syndax Pharmaceuticals Short Interest Geron Short Interest Amneal Pharmaceuticals Short Interest Schrödinger Short Interest Catalyst Pharmaceuticals Short Interest Supernus Pharmaceuticals Short Interest Ardelyx Short Interest Avidity Biosciences Short Interest Structure Therapeutics Short Interest Morphic Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HRMY) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club